Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1994 Jul;39(1):1-14.
doi: 10.1007/BF01517174.

Relevance of the T cell receptor for immunotherapy of cancer

E Weidmann  1 , M Trucco, T L Whiteside
Affiliations
Review

Relevance of the T cell receptor for immunotherapy of cancer

E Weidmann et al. Cancer Immunol Immunother. 1994 Jul.
No abstract available

PubMed Disclaimer

References

    1. Aebersold P, Hyatt C, Johnson S, Hines K, Korcak L, Sanders M, Lotze M, Topalian S, Yang J, Rosenberg SA. Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: association with clinical response. J Natl Cancer Inst. 1991;83:932. - PubMed
    1. Alt FW, Oltz EM, Young F, Gorman J, Taccioli G, Chen J. VDJ recombination. Immunol Today. 1992;13:306. - PubMed
    1. Anichini A, Fossati G, Parmiani G. Clonal analysis of cytotoxic T-lymphocyte response to autologous human metastatic melanoma. Int J Cancer. 1985;35:683. - PubMed
    1. Atzpodien J, Korfer A, Franks CR, Poliwoda H, Kirchner H. Home therapy with recombinant interleukin 2 and interferon alpha 2b in advanced human malignancies. Lancet. 1990;335:1509. - PubMed
    1. Aulitsky W, Gastl G, Aulitsky WE, Herold M, Kemmler J, Mull B, Frick J, Huber C. Successful treatment of metastatic renal cell carcinoma with a biologic active dose of recombinant interferon gamma. J Clin Oncol. 1989;7:1875. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources